2m 2m 2m 2m 2m 2m 2m
Artivion (AORT)
NYSE
$20.51-$0.18 (-0.85%)
Price as of Jun 23, 2026 5:39 PM EDT- $977.2MMarket Cap
- -34.75%1-Year Change
- Medical DevicesIndustry
Artivion (AORT)
$20.51-$0.18 (-0.85%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
BLACKROCK INC. | 14.88% | 7.2M | -17,549 (-0.24%) | Dec 31, 2022 |
VANGUARD GROUP INC | 5.79% | 2.8M | +61,658 (+2.19%) | Dec 31, 2022 |
MACQUARIE GROUP LTD | 5.49% | 2.7M | +68,616 (+2.58%) | Dec 31, 2022 |
WELLINGTON MANAGEMENT GROUP LLP | 4.69% | 2.3M | +876,782 (+38.54%) | Dec 31, 2022 |
MORGAN STANLEY | 4.47% | 2.2M | +199,634 (+9.20%) | Dec 31, 2022 |
JUNIPER INVESTMENT COMPANY, LLC | 4.31% | 2.1M | 0 (0.00%) | Dec 31, 2022 |
STATE STREET CORP | 3.46% | 1.7M | +122,484 (+7.29%) | Dec 31, 2022 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
iSHARES TRUST | 9.64% | 4.7M | +48,631 (+1.04%) | Mar 31, 2026 |
DELAWARE GROUP EQUITY FUNDS V | 3.97% | 1.9M | -24,604 (-1.28%) | Nov 28, 2025 |
VANGUARD INDEX FUNDS | 3.92% | 1.9M | +40,920 (+2.15%) | Mar 31, 2026 |
FIDELITY SECURITIES FUND | 2.17% | 1.1M | -90,100 (-8.54%) | Jan 31, 2026 |
CONESTOGA FUNDS | 1.51% | 731,920 | +731,920 (+100.00%) | Mar 31, 2026 |
SPDR SERIES TRUST | 1.42% | 689,262 | +45,709 (+6.63%) | Mar 31, 2026 |
LOOMIS SAYLES FUNDS II | 1.13% | 548,606 | +83,529 (+15.23%) | Mar 31, 2026 |
Current Ownership Distribution
- Institutions138.0M (58.30%)
- Mutual Funds95.4M (40.31%)
- Insiders3.3M (1.39%)
- Other0 (0.00%)
Insider Transactions
- 1.39% (3.3M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 8Number of InsiderSelling (last 12 months)
- $446.0MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
GREEN ANDREW M SVP, Regulatory and Quality | Exempt | Jun 11, 2026 | $0.00 | 14,001 | $0.00 | 0 |
GREEN ANDREW M SVP, Regulatory and Quality | Exempt | Jun 11, 2026 | $0.00 | 30,000 | $0.00 | 0 |
GREEN ANDREW M SVP, Regulatory and Quality | Exempt | Jun 11, 2026 | $258,178.44 | 14,001 | $18.44 | 74,260 |
GREEN ANDREW M SVP, Regulatory and Quality | Sell | Jun 11, 2026 | $289,918.71 | 14,001 | $20.71 | 60,259 |
GREEN ANDREW M SVP, Regulatory and Quality | Exempt | Jun 11, 2026 | $330,900.00 | 30,000 | $11.03 | 90,259 |
GREEN ANDREW M SVP, Regulatory and Quality | Sell | Jun 11, 2026 | $620,820.00 | 30,000 | $20.69 | 60,259 |
Holloway Jean F SVP, General Counsel | Sell | Mar 04, 2026 | $340,556.00 | 8,962 | $38.00 | 185,095 |
Mackin James P President & CEO | Sell | Mar 03, 2026 | $675,692.16 | 17,887 | $37.78 | 947,275 |
Stanton Marshall S. SVP, Clinical & MD Affair | Sell | Mar 03, 2026 | $81,179.76 | 2,149 | $37.78 | 60,097 |
Horton Amy VP, Chief Accounting Officer | Sell | Mar 03, 2026 | $34,035.82 | 901 | $37.78 | 139,088 |
Holloway Jean F SVP, General Counsel | Sell | Mar 03, 2026 | $145,171.63 | 3,843 | $37.78 | 194,057 |
Davis John E Chief Commercial Officer | Sell | Mar 03, 2026 | $172,747.82 | 4,573 | $37.78 | 230,794 |
Berry Lance A EVP, COO, CFO & Treasurer | Sell | Mar 03, 2026 | $238,590.69 | 6,316 | $37.78 | 210,827 |
Horton Amy VP, Chief Accounting Officer | Award | Mar 02, 2026 | $0.00 | 7,475 | $0.00 | 139,989 |
Horton Amy VP, Chief Accounting Officer | Sell | Mar 02, 2026 | $24,373.96 | 641 | $38.02 | 132,514 |
Davis John E Chief Commercial Officer | Sell | Mar 02, 2026 | $105,861.32 | 2,784 | $38.02 | 206,522 |
Stanton Marshall S. SVP, Clinical & MD Affair | Sell | Mar 02, 2026 | $57,531.67 | 1,513 | $38.02 | 40,408 |
Davis John E Chief Commercial Officer | Award | Mar 02, 2026 | $0.00 | 28,845 | $0.00 | 235,367 |
Berry Lance A EVP, COO, CFO & Treasurer | Sell | Mar 02, 2026 | $196,892.93 | 5,178 | $38.02 | 176,269 |
Mackin James P President & CEO | Award | Mar 02, 2026 | $0.00 | 116,948 | $0.00 | 965,162 |
Stanton Marshall S. SVP, Clinical & MD Affair | Award | Mar 02, 2026 | $0.00 | 21,838 | $0.00 | 62,246 |
Mackin James P President & CEO | Sell | Mar 02, 2026 | $566,989.28 | 14,911 | $38.02 | 848,214 |
Holloway Jean F SVP, General Counsel | Sell | Mar 02, 2026 | $83,008.36 | 2,183 | $38.02 | 170,105 |
Berry Lance A EVP, COO, CFO & Treasurer | Award | Mar 02, 2026 | $0.00 | 40,874 | $0.00 | 217,143 |
Holloway Jean F SVP, General Counsel | Award | Mar 02, 2026 | $0.00 | 27,795 | $0.00 | 197,900 |
Mackin James P President & CEO | Sell | Feb 24, 2026 | $497,417.65 | 13,936 | $35.69 | 766,095 |
Davis John E Chief Commercial Officer | Sell | Feb 24, 2026 | $74,062.98 | 2,075 | $35.69 | 188,868 |
Berry Lance A EVP, COO, CFO & Treasurer | Sell | Feb 24, 2026 | $160,083.11 | 4,485 | $35.69 | 143,965 |
Holloway Jean F SVP, General Counsel | Sell | Feb 24, 2026 | $59,535.92 | 1,668 | $35.69 | 152,203 |
Mackin James P President & CEO | Award | Feb 24, 2026 | $0.00 | 97,030 | $0.00 | 863,125 |